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Abstract
Trichomonas vaginalis is an extracellular eukaryotic parasite that causes the most common,
non-viral sexually transmitted infection worldwide. Although disease burden is high, molec-
ular mechanisms underlying T. vaginalis pathogenesis are poorly understood. Here, we
identify a family of putative T. vaginalis rhomboid proteases and demonstrate catalytic activ-
ity for two, TvROM1 and TvROM3, using a heterologous cell cleavage assay. The two T.
vaginalis intramembrane serine proteases display different subcellular localization and sub-
strate specificities. TvROM1 is a cell surface membrane protein and cleaves atypical model
rhomboid protease substrates, whereas TvROM3 appears to localize to the Golgi apparatus
and recognizes a typical model substrate. To identify TvROM substrates, we interrogated
the T. vaginalis surface proteome using both quantitative proteomic and bioinformatic
approaches. Of the nine candidates identified, TVAG_166850 and TVAG_280090 were
shown to be cleaved by TvROM1. Comparison of amino acid residues surrounding the pre-
dicted cleavage sites of TvROM1 substrates revealed a preference for small amino acids in
the predicted transmembrane domain. Over-expression of TvROM1 increased attachment
to and cytolysis of host ectocervical cells. Similarly, mutations that block the cleavage of a
TvROM1 substrate lead to its accumulation on the cell surface and increased parasite
adherence to host cells. Together, these data indicate a role for TvROM1 and its substrate
(s) in modulating attachment to and lysis of host cells, which are key processes in T. vagina-
lis pathogenesis.
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Author Summary
Trichomonas vaginalis, a common pathogen with a worldwide distribution, causes a sexu-
ally transmitted infection and exacerbates other diseases. Estimated to infect over a million
people annually in the United States alone, the Center for Disease Control and Prevention
categorized trichomoniasis as one of five neglected parasitic diseases in the US in 2014.
Only one class of drug is available to treat T. vaginalis infection, making discovery of para-
site factors contributing to host colonization critical for the development of new therapeu-
tics. Here we report the first characterization of T. vaginalis intramembrane rhomboid
proteases. One protease, TvROM1, is shown to increase the parasite’s association with and
destruction of host cells. We further identified two TvROM1 substrates, one of which we
demonstrate is involved in modulating host: parasite interactions. This study highlights
the involvement of rhomboid proteases in T. vaginalis pathogenic processes, and provides
further support for targeting parasite surface proteases for therapeutic intervention.
Introduction
Trichomonas vaginalis is an extracellular, eukaryotic parasite that is the causative agent of
trichomoniasis, the most common non-viral sexually transmitted infection in the world [1].
Approximately 276 million people worldwide become newly infected each year [1]. In the
United States, an estimated 3.7 million people are currently infected [2]. Symptoms and out-
comes of infection include vaginitis, urethritis, prostatitis, infertility, and adverse pregnancy
outcomes (reviewed in Petrin et al. 1998) [3, 4]. T.vaginalis infection is associated with an
increased risk of HIV acquisition [5] and potential transmission [6] due to HIV target cell
recruitment to the site of infection [7] and increased viral shedding upon co-infection [8, 9].
T. vaginalis is also associated with cervical cancer [10, 11] and aggressive prostate cancer [12,
13]. Due to the high burden, threat of illness, and understudied nature of T. vaginalis infection,
trichomoniasis has been recently recognized as one of the United States’ neglected parasitic
infections [4, 14, 15].
Although the magnitude of parasite infection is high, little is known about how T. vaginalis
colonizes the human host and causes disease [3, 16]. As an extracellular organism that thrives
in the changing and physiologically diverse environment of the urogenital tract of men and
women, T. vaginalis likely utilizes multiple mechanisms to establish an infection and persist.
The parasite attaches to multiple host cell types such as vaginal and prostate epithelial cells
[17], red blood cells [18], and is capable of acquiring nutrients from them through host cell
lysis. T. vaginalis can also bind together to form clusters [19]. Parasite cell aggregates are
observed upon axenic growth and when placed on monolayers of host cells. However, only a
few of the molecular players that mediate and regulate these parasite-parasite or host-parasite
interactions have been identified [16, 19, 20].
Recent genomic, transcriptomic, and proteomic studies of T. vaginalis have aided the identi-
fication of protein families that may play important roles in T. vaginalis cell biology and patho-
genesis [21–24]. In studies analyzing the surface proteome of T. vaginalis, we identified a
rhomboid-like protein [23]. Rhomboid proteases are polytopic serine proteases that are local-
ized to membranes where they encounter and cleave their substrates. Thus they belong to the
intramembrane-cleaving protease (I-CLiPs) class of enzymes [25]; however, rhomboid prote-
ases differ from most I-CLiPs in that their cleavage products are often released to the outside of
the cell. Rhomboid proteases were first described in Drosophila melanogaster, where they shed
growth factors from the membrane to initiate cell signaling in neighboring cells [26–28].
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Rhomboid proteases are among the most conserved families of polytopic membrane pro-
teins [29] and have been suggested to be one of the most ancient regulatory enzymes [25]. In
addition to activating cell signaling pathways, rhomboid proteases have been reported to play
roles in quorum sensing [30, 31], regulation of mitochondrial morphology [32], and phagocy-
tosis [33]. Moreover, in intracellular parasites like Toxoplasma [34–38] and Plasmodium [39–
43] as well as the extracellular parasite Entamoeba histolytica [44] rhomboid proteases cleave
parasite adhesins.
One of the greatest challenges in uncovering the biological functions of rhomboid proteases
has been the identification of their substrates. For example, the substrate for the most studied
bacterial rhomboid, Escherichia coli GlpG, is still unknown [45]. Rhomboid proteases from
evolutionarily divergent organisms are capable of recognizing and cleaving a common set of
substrates [26, 31, 34, 39, 44, 46]. This property has allowed the identification of active rhom-
boid proteases, from diverse organisms, in the absence of a known substrate.
Rhomboid proteases and other I-CLiPs evolved separately from soluble proteases [25],
hence the mechanism(s) they use for substrate recognition and cleavage is also predicted to be
different, as recent studies have begun to reveal [47–49]. Selection of a specific rhomboid sub-
strate is dictated by transmembrane (TM) segment dynamics of the substrate [49]. In particu-
lar, helix-destabilizing residues in the TM domain appear to be required for the substrate to
exit the membrane and reside in the enzyme’s inner active site [49]. There is also a preference
for certain amino acids surrounding the cleavage site. Cleavage of the substrate occurs between
small amino acids at positions designated P1 and P1’ [46, 50, 51]. Additional preferences for
particular amino acids at the P4 and P2’ sites for the eubacterial AarA rhomboid led to the pre-
diction of a universal recognition motif for substrate binding by rhomboid proteases [46].
However, further studies revealed that most eukaryotic rhomboid proteases do not conform to
this prediction [49]. The discovery of additional substrates will aid in defining specific substrate
features that promote rhomboid protease cleavage and how these may differ between different
classes of rhomboid proteases.
In this study, we report the identification and characterization of two active T. vaginalis
rhomboid proteases (TvROM1 & TvROM3). Exogenous expression of TvROM1 increases
attachment to and cytolysis of host ectocervical cells, which are two phenotypes implicated in
pathogenesis. Using quantitative proteomics and bioinformatics, we identified and verified two
TvROM1 substrates, TVAG_166850 and TVAG_280090. Neither TvROM1 substrate is
cleaved by TvROM3, hence the two enzymes have different natural substrates, consistent with
their specificity for different model substrates and different subcellular localizations. Impor-
tantly, the T. vaginalis substrates identified for TvROM1 belong to a family of putative adhesins
previously implicated in pathogenesis [20, 23]. Together, our observations demonstrate a role
for TvROM1 and its substrate(s) in modulating parasite attachment and cytolysis of host cells.
Results
Identification of active rhomboid proteases in T. vaginalis
To assess the function of rhomboid proteases in the extracellular parasite T. vaginalis, we inter-
rogated its genome (http://trichdb.org/trichdb) and found nine genes annotated as “rhomboid-
like”. Bioinformatic analysis of these genes revealed that only four encode both a serine (Ser)
and a histidine (His) at the top of TMs 4 and 6 which are predicted to form the catalytic dyad
for substrate cleavage (S1 Fig). The proteins encoded by these four genes also have the Gly-
X-Ser-X motif, (X = amino acid) that surrounds and identifies the catalytic serine residue [52].
We named these putative active T. vaginalis rhomboid proteases TvROM1-4 (TrichDB acces-
sion numbers TVAG_112900, TVAG_359500, TVAG_476950, TVAG_161010). The other
Trichomonas vaginalis Rhomboid Proteases and Substrates
PLOS Pathogens | DOI:10.1371/journal.ppat.1005294 December 18, 2015 3 / 25
five gene products (TrichDB accession numbers TVAG_282180, TVAG_378960, TVAG_
233140, TVAG_183030, TVAG_037580) lack one or both catalytic residues and are likely pro-
teolytically inactive. TVAG_233140, which lacks a catalytic His, was detected in the surface
proteome of T. vaginalis [23]. We focused our attention on the rhomboid proteins predicted to
be active proteases. S1 Fig summarizes additional features found in the four predicted active T.
vaginalis rhomboid proteases. The alignment in S1 Fig also reveals differences in the N- and C-
termini amongst TvROMs 1–4, a feature that has been previously noted when comparing
rhomboid protease sequences from multiple organisms [52].
Localization of TvROMs in T. vaginalis
The genes encoding the predicted active rhomboids were cloned under the control of the
strong α-SCS promoter with N-terminal hemagglutinin (HA) tags and transfected into T. vagi-
nalis. TvROMs were tagged at their N-terminus based on reports that HA-N-terminally-tagged
rhomboid proteases localize properly and are active, while addition of a C-terminal tag can
abolish proteolytic activity [34, 39, 44]. Furthermore, all TvROMs lack predicted N-terminal
signal peptides as analyzed by several signal peptide and membrane topology prediction pro-
grams. As has been observed for other multi-spanning membrane proteins, TvROMs 1–4 are
predicted to be properly targeted and inserted in the membrane via their first TM domain [53].
The subcellular localization of the proteins was determined in transfectants using indirect
immunofluorescence assays (IFA) with an anti-HA antibody. Initial analyses indicated a cell
surface localization of HA-TvROM1. To confirm this localization, transfectants were labeled
using membrane-impermeable biotin as described previously [23] and a co-localization of the
HA-TvROM1 signal with the biotinylated cell surface was observed (Fig 1A–1C). No back-
ground staining was observed in non-biotinylated parasites used as a negative control.
In contrast to the cell surface localization of HA-TvROM1, HA-TvROM2 and HA-Tv-
ROM3 were located in a line structure next to the nucleus (Fig 1D, 1E, 1F, and 1G, respec-
tively), which is likely the Golgi apparatus. Many rhomboid proteases have been localized in
the Golgi apparatus, including the founding member of the rhomboid family, Drosophila
Rhomboid-1 (DmRho1) [26] and the Toxoplasma gondii TgROM2 [54]. Prior to mitosis, the
T. vaginalis Golgi apparatus elongates and then divides through medial fission of each cisternae
in a process called Golgikinesis, forming two Golgi ribbons [55]. We observed a similar pattern
of staining adjacent to the nucleus in dividing cells where HA-TvROM2 (Fig 1D and 1E) and
HA-TvROM3 localize, providing additional support for a Golgi localization of these proteins.
We were unable to detect expression of HA-TvROM4 in transfectants and therefore did not
continue to analyze this protein.
TvROM1 and TvROM3 are active proteases
We tested the proteolytic activities of TvROM1-3 using an established heterologous cell cleav-
age assay [39]. Synthetic open reading frames of each TvROM were designed to match codon
bias of human cells to facilitate expression in human cells. These proteases were HA-tagged
and co-expressed in HEK293 cells with model rhomboid protease substrates tagged at the N-
terminus with GFP or doubly tagged with an N-terminal GFP tag and a C-terminal FLAG tag.
Cleavage was then assessed by detection of released GFP-tagged substrates of the predicted
size. Rhomboid proteases known to cleave the model substrate being tested were also co-trans-
fected with the substrate as a positive control. Cells transfected only with the model substrate
or co-transfected with catalytically inactive rhomboid mutants served as negative controls.
We first tested whether TvROMs cleave the D.melanogaster rhomboid substrate Spitz [26],
a canonical rhomboid substrate cleaved by rhomboid proteases from most organisms tested
Trichomonas vaginalis Rhomboid Proteases and Substrates
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[34, 39, 44, 51, 56]. We discovered that TvROM3 was the only TvROM that could consistently
cleave Spitz, albeit weakly. TvROM3 cleavage was more efficient with APP+Spi7, a chimeric
substrate in which the first 7 residues of the amyloid precursor protein (APP) TM segment
were replaced with those from Spitz (Fig 2A-lane 5). The positive control DmRho1 cleaved
APP+Spi7 (Fig 2A-lane 2) releasing the cleaved fragment into the media. Cleavage by
TvROM3 was specific as no cleavage product was detected with the TvROM3 His181Ala
mutant (Fig 2A-lane 6).
Plasmodium falciparum rhomboid 4 (PfROM4) displays ‘atypical’ specificity, because it can-
not process Spitz yet cleaves many Plasmodium adhesins [39]. Since TvROM1 was unable to
cleave Spitz, we tested its ability to cleave Plasmodium adhesins erythrocyte-binding antigen
175 (EBA-175) protein (Fig 2B) and the BA erythrocyte binding ligand (BAEBL/EBA140) pro-
tein (S2A Fig). TvROM1 cleaved EBA-175 (Fig 2B-lane 3) and BAEBL (S2A Fig -lane 3) effi-
ciently. Conversely, the TvROM1 His316Ala mutant did not cleave these two proteins (Fig 2B-
lane 4 and S2A Fig -lane 4). The ability of TvROM1 to cleave Plasmodium adhesins but not
Spitz protein categorizes it as having atypical substrate specificity [39]. Importantly, in addition
to PfROM4 and Entamoeba histolytica rhomboid 1 (EhROM1), TvROM1 is the third parasite
rhomboid protease that displays atypical substrate specificity [39, 44] suggesting this may be a
common feature of eukaryotic parasite rhomboid proteases. Since TvROM1 displayed similar
Fig 1. Subcellular localization of HA-tagged TvROMs in T. vaginalis transfectants. Fluorescence
microscopy images of indirect immunofluorescence assays (IFA) performed on T. vaginalis exogenously
expressing N-terminal hemagglutinin (HA)-tagged TvROMs 1–3. (A-C) HA-TvROM1 transfectants were
reacted with membrane impermeable biotin (EZ-Link-Sulfo-NHS-SS-Biotin) and IFA was then performed
using formaldehyde fixation and staining with rabbit anti-HA (A-red) and a mouse anti-Biotin (B-green)
antibodies. (C) Merge shows co-localization of HA-TvROM1 with the biotin-labeled T. vaginalis cell surface,
scale bar = 10 μm. IFA images of HA-TvROM2 (D & E) and HA-TvROM3 (F & G) using a mouse anti-HA
antibody (green) and nuclear staining using 4’-6’-diamidino-2-phenylindole (DAPI-blue). HA-TvROM2 and
HA-TvROM3 show localization in a line structure adjacent to the nucleus, scale bar = 5 μm. Two juxtanuclear
structures of different sizes can be observed in early and late dividing cells in HA-TvROM2 transfectants (D,
see arrows). Phase images are shown on the right.
doi:10.1371/journal.ppat.1005294.g001
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Fig 2. TvROM catalytic activity analyses. The activity of T. vaginalis rhomboid proteases were tested by co-transfecting the proteases with known model
rhomboid substrates in a heterologous cell cleavage assay using HEK293 cells. Proteases were HA tagged and substrates contained an N-terminal GFP tag
Trichomonas vaginalis Rhomboid Proteases and Substrates
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substrate specificity as PfROM4, we determined whether TvROM1 also cleaves EBA-175 at the
same site as PfROM4. The FLAG-tagged C-terminal cleavage product produced by TvROM1
and PfROM4 co-transfectants was immunoprecipitated and the cleavage site was determined
by MALDI-TOF analysis. We found that TvROM1 cleaves EBA-175 between Ala and Gly (Fig
2C) as previously found for PfROM4 [42]. Therefore, TvROM1 also cleaves its substrate
between two small amino acids.
TvROM1 could also cleave human EphrinB3 (Fig 2D-lane 3), and bacterial TatA proteins
(Fig 2E-lane 3), which are substrates of the human RHBDL2 [57] and the bacterial AarA [30]
rhomboid proteases, respectively. DmRho1 served as a positive control in the EphrinB3 and
TatA cleavage assays (Fig 2D-lane 2 and Fig 2E-lane 2, respectively). Interestingly, although
DmRho1 cleaves Spitz and these additional substrates, TvROM1 cleaved EphrinB3 and TatA,
but not Spitz. Cleavage of EphrinB3 and TatA by TvROM1 was specific, since the TvROM1
His316Ala mutant did not produce cleavage fragments (Fig 2D-lane 4 and Fig 2E-lane 4). Con-
versely, TvROM3 did not specifically cleave EBA-175 (Fig 2B- lanes 5 and 6), EphrinB3 (Fig
2D-lanes 5 and 6), or TatA (Fig 2E-lanes 5 and 6). Taken together, these results identify differ-
ent substrate specificities for TvROM1 and TvROM3 (summarized in Fig 2F).
TvROM2 produced cleavage fragments of Spitz (S2D Fig-lane 4), however, the fragments
were also produced by the TvROM2 His270Ala mutant (S2D Fig -lane 5). As endogenous
metalloproteases have been shown to cleave and release rhomboid substrates in the heterolo-
gous cell cleavage assay [26, 34, 39], we added a wide-spectrum metalloprotease inhibitor
(10 μM batimastat-BB-94) in assays testing whether TvROM2 cleaves EphrinB3 (S2B Fig). The
inhibitor greatly reduced the appearance of the predicted EphrinB3 cleavage fragment pro-
duced by TvROM2 (S2B Fig-lane 3 vs. lane 7) and the TvROM2 mutant (S2B Fig-lane 4 vs.
lane 8) but not by TvROM1 (S2B Fig -lane 2 vs. 6) that we used as a positive control. Therefore
the cleavage products observed with the other substrates in the TvROM2 co-transfectants (S2D
and S2E Fig, lanes 4 and 5) are also likely due to endogenous metalloprotease activity and not
rhomboid protease activity.
Serine protease activity and TvROM1 contributes to T. vaginalis
attachment to and cytolysis of host ectocervical cells
To investigate the biological role of TvROMs and their possible contribution to parasite-host
interactions, we tested the effect of the serine protease inhibitor 3,4-dichloroisocoumarin
(3,4-DCI) on parasite attachment to and lysis of host cells. 3,4-DCI has been shown to inhibit
the activity of rhomboid proteases from multiple organisms [33, 34, 40, 58]. The effect of
3,4-DCI on parasite attachment to host cells was tested by exposing T. vaginalis to ectocervical
cell monolayers for 30 min in the presence of increasing concentrations of 3,4-DCI. Unat-
tached parasites were then washed away and the number of attached parasites was quantified
to allow detection. (A, B, D and E)Whole cell lysates (WCL) and conditioned media (CM) collected from co-transfectants was analyzed byWestern blot
analyses [39]. Top panels: rhomboid protease detected in WCL using an anti-HA antibody;middle panels: full-length (FL, filled arrowheads) and cleaved
substrates (open arrowheads) detected in WCL using an anti-GFP antibody; bottom panels: cleaved substrate fragments detected in CM using an anti-GFP
antibody (open, red arrowheads). The substrates tested were (A) APP+7 residues of the Drosophila melanogaster Spitz protein encompassing the rhomboid
protease cleavage site (APP+Spi7), (B) Plasmodium falciparum EBA-175, (D) human EphB3, and (E) Providencia stuartii TatA. The positive control HA-
tagged rhomboid protease (lane 2) used for cleavage of Spitz (A), human EphB3 (D), and TatA (E) was DmRho1; the positive control protease for cleavage
of EBA-175 (B) was HA-tagged PfROM4 (lane 2). Negative controls (lane 1) were transfected with only substrates. TvROM1/TvROM3 = wild type protease;
TvROM1mut/TvROM3mut = protease with the catalytic histidine mutated to alanine. TvROM3 was found to cleave only the Spitz TM domain segment of
APP+Spi7 (Amiddle panel, lane 5) whereas TvROM1 does not cleave the Spitz sequence (A bottom panel, lane 3) but does cleave the other 3 substrates
(B, D, and E bottom panels, lane 3). (F) Summary of the cleavage data shown in panels A, B, D, and E. (C) The location of EBA-175 cleavage by PfROM4
(control; top panel) and TvROM1 (bottom panel) determined by subjecting the immunoprecipitated cleavage fragment to MALDI-TOF analysis. Red arrows
indicate that both proteases cleave the substrate between the two small amino acids alanine (A) and glycine (G).
doi:10.1371/journal.ppat.1005294.g002
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(as previously described [17]). A dose-response effect was observed even with low concentra-
tions of 10 and 15 μM 3,4-DCI, which decreased attachment to host cells 40% and 64%, respec-
tively, compared to vehicle-treated parasites (Fig 3A). To test the effect of 3,4-DCI on cytolysis
of host cells, we exposed T. vaginalis to ectocervical cell monolayers for three hours in the pres-
ence of different 3,4-DCI concentrations and then assessed host cell lysis by measuring LDH
released from damaged cells as described [17]. Similar to the observed reduction in attachment,
cytolysis of host cells was reduced by 25%, 61% and 73% in the presence of 5, 10 and 15 μM
3,4-DCI, respectively (Fig 3B). No effect on the viability of the parasites or host cells was
observed at the concentrations used for both the attachment and cytolysis assays. These results
suggest that serine proteases likely play a role in two critical processes that contribute to T.
vaginalis destruction of host cells.
To test the role of individual TvROMs specifically, we compared the ability of parasites
exogenously expressing HA-tagged TvROMs to attach to and lyse host cells. Parasites express-
ing additional exogenous HA-TvROM1 had a 1.6-fold increase in attachment to host cells
compared to empty vector control transfectants (p-value<0.01) (Fig 3C). Additionally,
exogenous expression of HA-TvROM1 resulted in a 4.2-fold increase in host cell lysis (p-
value<0.01) (Fig 3D). The involvement of TvROMs in these processes was limited to
TvROM1, as exogenous expression of TvROM2 and TvROM3 did not lead to increased attach-
ment to or lysis of host cells.
Fig 3. Serine protease activity and TvROM1 contribute to T. vaginalis attachment and lysis of ectocervical cells. (A) Fluorescently labeled T. vaginalis
incubated with ectocervical cell monolayers in the presence of increasing concentrations of the serine protease inhibitor 3,4-dichloroisocoumarin (3,4-DCI)
followed by quantification of adhered parasites. The average fold change in attachment compared to vehicle control for four experiments each performed in
triplicate is shown. Error bars denote the standard error, **p<0.01. (B) Parasites incubated with ectocervical cell monolayers in the presence of increasing
3,4-DCI followed by assessment of ectocervical cell lysis. The average fold change in cytolysis compared to vehicle control for three experiments performed
in triplicate is shown. Error bars denote the standard error, **p<0.01. (C) Average fold difference in attachment of HA-TvROM1 transfectants compared to
empty vector transfectants shown for four experiments each conducted in triplicate, with standard error shown as error bars, **p<0.01. (D) Average fold
change in cytolysis of ectocervical cells by HA-TvROM1 transfectants compared to empty vector transfectants, results are from four experiments performed
in triplicate. Standard error is shown as error bars, **p<0.01.
doi:10.1371/journal.ppat.1005294.g003
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TvROM1 substrate identification using quantitative proteomics
Having demonstrated that TvROM1 is an active protease that modulates attachment to and
lysis of host cells, we sought to identify its substrates using a quantitative proteomics approach.
Given the cell surface localization of TvROM1, we identified proteins that were differentially
released into the media by TvROM1 transfectants treated with the serine protease inhibitor
3,4-DCI compared to DMSO vehicle control (see flow chart in Fig 4A). Proteins released into
the media were collected and differentially labeled using stable isotope dimethyl labeling [59]
to allow quantitative comparisons of protein abundance, with the prediction that inhibition of
TvROM1 activity would reduce the release of its plasma membrane substrates. S1 Table lists
and Fig 4B shows the distribution of all the proteins identified in a combined analysis of two
independent mass spectrometry experiments. Of the proteins identified, seventeen protein
groups decreased by more than 50% with 3,4-DCI vs. vehicle control treatment, with a statisti-
cally significant decrease observed for seven protein groups (see S1 Table). Five proteins of the
seven protein groups (TVAG_166850, TVAG_573910, TVAG_245580, TVAG_425470,
TVAG_393390) have a predicted TM domain and type 1 topology (N-terminus outside cell-
TM domain-C-terminus inside cell), which constitute the minimal features of rhomboid prote-
ase substrates. The abundance of the five candidate substrates in the T. vaginalismedia was
reduced 60–67% in the presence of 50 μM 3,4-DCI (Fig 4C). Mass spectrometry data from
these experiments have been deposited to Chorus and are available for download (https://
chorusproject.org, project ID 969).
The ability of TvROM1 to cleave the TM domains of the five candidate substrates was tested
using the HEK293 heterologous cell cleavage assay. Initial attempts to express the full-length T.
vaginalis substrates resulted in retention of these large proteins in the ER. Therefore, to assess
cleavage at the cell surface, a chimeric protein of GFP-EBA-175 with its TM domain replaced
with each of the five putative substrate’s TM domain was constructed and co-expressed with
either TvROM1 or a TvROM1 His316Ala mutant. We found that only the TM domain of
TVAG_166850 could be specifically cleaved by TvROM1 (Fig 4D, bottom panel, lane 2, and
S3A–S3D Fig) but not the TvROM1 His316Ala mutant (Fig 4D, bottom panel, lane 3).
Although we observed release of TVAG_573910 into the media, cleavage was not dependent
on co-transfection with TvROM1 (S3A Fig -lanes 1 and 2). We also tested whether any of the
putative substrates could be cleaved by TvROM3, the other active rhomboid protease identified
(Fig 2), but TvROM3 failed to cleave any of the five putative substrates (see S3A–S3D Fig).
Inspection of the amino acids in the TM domain of the five putative substrates (Fig 4C)
revealed that the four proteins that were not cleaved (TVAG_573910, TVAG_245580,
TVAG_425470, and TVAG_393390) contain residues at the top of the TM domain that fit the
previously published Strisovsky et al. motif [46]. Therefore, the substrate specificity of both
TvROM1 and TvROM3 appear to differ from the bacterial-like rhomboid specificity defined
by the Strisovsky et al. motif. Instead, the TM domain of the cleaved substrate TVAG_166850,
has a predominant presence of the small amino acid alanine, and the helix relaxing residue gly-
cine [60, 61] (Fig 4C). This finding led us to investigate possible substrate determinants that
might aid in identification of additional T. vaginalis rhomboid substrates.
Screening the T. vaginalis surface proteome for TM domains similar to
TMs in parasite rhomboid protease substrates identifies an additional
TvROM1 substrate and reveals features of T. vaginalis substrate
specificity
Rhomboid proteases cleave near or at the external face of the TM domain of the substrate.
Since the substrate’s overall TM dynamics has been found to be the governing feature defining
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a rhomboid substrate [49], a subset of amino acids surrounding the cleavage site are likely to
play a major role in promoting a substrate conformation that leads to cleavage [51]. Thus, we
compiled and compared established and predicted cleavage sites for 20 rhomboid substrates
from other eukaryotic parasites: Toxoplasma gondii, Plasmodium falciparum, and Entamoeba
histolytica [34–37, 39, 41, 42, 44, 51, 54]. The resulting comparison revealed a preference for
Fig 4. Use of quantitative proteomics identifies a putative TvROM1 substrate. (A) Flow chart of the approach taken to identify putative substrates for
TvROM1 using quantitative proteomics of cell supernatants from HA-TvROM1 T. vaginalis transfectants treated with vehicle or 50 μM 3,4-DCI serine
protease inhibitor. (B) The profile of proteins identified in two independent mass spectrometry experiments and the magnitude of change on a log2 scale,
errors bars denote the standard error. Proteins that decreased with 3,4-DCI treatment have log2(DCI/DMSO) ratios<0, and those that increased are >0. (C)
The predicted TM domains of the five putative substrates identified inA, and the percent decrease in protein levels with 3,4-DCI vs. DMSO vehicle treatment
is shown. Capital letters indicate amino acids of the predicted TM domain, lowercase letters denote amino acids found outside the predicted TM domain. (D)
The TM domain of TVAG_166850 is cleaved by TvROM1. A fusion protein composed of GFP-P. falciparum EBA-175 and the TVAG_166850 TM domain was
co-expressed with HA-TvROM1 (lane 2) or a TvROM1 catalytic His to Ala mutant (lane 3) using the HEK293 heterologous cell cleavage assay. Negative
control lacked co-transfection with a TvROM (lane 1). Western blot analysis of whole cell lysates (top and middle panels) and media (bottom panel) was
performed as described in text and Fig 2 legend. The expression of TvROM1 proteins and the substrate (filled arrowhead) is confirmed in top and middle
panels, respectively. Bottom panel shows release of the cleaved substrate (open, red arrowhead) specifically in TvROM1 co-transfectants. The remaining
putative substrates were not cleaved by TvROM1 or TvROM3 (see S3 Fig).
doi:10.1371/journal.ppat.1005294.g004
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specific residues (Fig 5A) from which we created a consensus called the parasite search motif
(Fig 5A). It is notable that this motif has little overlap with the consensus motif of the P4-P2’
sites preferred by bacterial rhomboid proteases [46].
Using the parasite search motif, we screened the T. vaginalis surface proteome [23] to iden-
tify putative TvROM1 substrates (see flowchart in Fig 5B). Of 314 proteins searched, seven pro-
teins had the motif positioned in the top part of the TM domain by at least two of three TM
prediction programs (S2 Table) and five of these were type 1, single TM proteins, typical of
rhomboid protease substrates. The predicted TM domains of the five putative substrates are
shown in Fig 5C. TVAG_166850, the only TvROM1 substrate identified in the quantitative
proteomics approach (Fig 4D-lane 2) is also one of the five candidate substrates identified by
this bioinformatics approach.
After confirming that the five candidate substrates are localized to the plasma membrane,
we performed heterologous cell cleavage assays to test whether their TM domains are cleaved
by TvROM1. In addition to the TM domain of TVAG_166850 (Fig 4D), we found that the TM
domain of TVAG_280090 is cleaved by TvROM1 (Fig 5D-lane 2, bottom panel). It is notable
that the TVAG_280090 protein has overall 55% identity and 69% similarity to TVAG_166850.
The TvROM1 His316Ala mutant could not cleave TVAG_280090’s TM domain (Fig 5D-lane
3, bottom panel), demonstrating specific cleavage. DmRho1 can also process
GFP-TVAG_280090 (S4F Fig -lane 4), providing further support that this protein is a rhom-
boid protease substrate. Similar to that observed for TVAG_166850 (S4A Fig -lane 6)
TvROM3 could not cleave the TM of TVAG_280090 (S4B Fig -lane 6). None of the remaining
candidate substrates were cleaved by TvROM1 or TvROM3 (S4A–S4E Fig).
Mutation of predicted rhomboid cleavage site in the putative substrate
TVAG_166850 increases its presence at the cell surface and leads to
greater parasite attachment to host cells
We have previously reported that the TvROM1 substrate identified in this study, TVAG_
166850, increases parasite attachment to host cells when exogenously expressed in a poorly
adherent T. vaginalis strain [23]. To address whether cleavage by TvROM1 influences
TVAG_166850’s ability to mediate host cell attachment we introduced mutations at the pre-
dicted rhomboid cleavage site. The predicted P1-P1’ site Ala672-Gly673 (AG) residues were
mutated to Phe-Phe (FF) residues, since we previously found that mutation of small amino
acids at the predicted cleavage site to bulky Phe significantly decrease rhomboid cleavage of the
T. gondii AMA1 substrate [38]. Fig 6A shows a graphical representation of GFP-TVAG_
166850 and the predicted rhomboid cleavage site. To verify that the mutations introduced into
the GFP-TVAG_166850AG/FF mutant affect TvROM1 cleavage, the HEK293 heterologous
cell cleavage assay was used to compare TvROM1 cleavage of the chimeric EBA-175 protein
containing either the wild type or mutant TM domain of TVAG_166850. The GFP-EBA-
175-TVAG_166850TMAG/FF mutant chimeric protein was cleaved 90% less than the chimeric
protein containing the wild type TM domain (Fig 6B-lane 4 vs. lane 9). Cleavage of the wild
type and mutant TM domains, above background levels, was not observed using the His316Ala
mutant of TvROM1 (Fig 6B-lane 5 and lane 10). Similarly, the Toxoplasma gondii TgROM5
that can also cleave the wild type TM domain of TVAG_166850 (Fig 6B-lane 3) and exhibited
limited cleavage of the mutant TM domain (Fig 6B-lane 8).
To test whether surface substrates of TvROM1 play a role in host: pathogen interactions, N-
terminally tagged GFP-TVAG_166850WT or the GFP-TVAG_166850AG/FF mutant were exog-
enously expressed in the poorly adherent T. vaginalis strain G3. The levels of wild type and
mutant proteins expressed and presented on the surface of transfectants were then measured
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Fig 5. Screening of the T. vaginalis surface proteome with a parasite searchmotif identifies an additional TvROM1 substrate. (A)Graphical
representation of the amino acids found in the predicted cleavage site of 20 parasite rhomboid protease substrates and the canonical Drosophila rhomboid
substrate Spitz. The height of an amino acid indicates its relative frequency. Residue colors demark the properties of their side chains: small = black (A and
G), basic = blue (K), aliphatic = orange (L, I, and V), green = uncharged, polar (Y, T, S, and N), nonpolar, nonaliphatic = purple (F and P). The predicted
cleavage site is marked by a red arrow. The most common amino acids in these proteins were used to generate a “parasite search motif” (shown below). (B)
Flow chart of the approach taken to identify putative TvROM1 substrates by searching the T. vaginalis surface proteome published by de Miguel et al. 2010
with the parasite search motif. (C) The accession numbers and predicted TM domain of the five putative surface proteome substrates are shown. The
parasite search motif is indicated by blue font. Capital letters indicate amino acids of the predicted TM domain, lower case letters denote amino acids found
outside the predicted TM domain. (D) The TM domain of putative substrate TVAG_280090 is cleaved by TvROM1. A GFP-EBA-175 chimeric protein that has
its TM domain replaced with that of TVAG_280090 was co-expressed with TvROM1 or TvROM1 catalytic His to Ala mutant (mut) in the HEK293
heterologous cell cleavage assay. Negative control lacked co-transfection with a TvROM (Negative-lane 1). Western blot analyses of whole cell lysates
confirm expression of the TvROM1 wt and mut proteins (top panel) and the full length substrate (filled arrowhead, middle panel). Analyses of conditioned
media from the co-transfectants show a GFP-tagged cleavage product in the media (red arrowhead, bottom panel) of TvROM1 co-transfectants (TvROM1)
and not in the TvROM1 catalytic His to Ala mutant (TvROM1mut). The remaining putative substrates were not cleaved by TvROM1 or TvROM3 (see S4 Fig).
doi:10.1371/journal.ppat.1005294.g005
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Fig 6. Phenotypic analysis of predicted rhomboid cleavage site mutation in the putative substrate TVAG_166850. (A) Predicted topology of the
putative substrate TVAG_166850 using the Spoctopus TM prediction program, illustrated using the TOPO2 graphical representation program.
TVAG_166850WT was tagged at the N-terminus with a GFP tag (green box). The predicted rhomboid cleavage site (scissors) and the predicted P1-P1’
cleavage site residues are highlighted in blue. The surrounding parasite search motif residues are highlighted in red. The predicted TM residues are shown
below. A rhomboid cleavage site mutant was generated by mutating the predicted Ala-Gly P1-P1’ residues (underlined in sequence) to Phe-Phe residues to
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using flow cytometry. The percent of cells expressing the GFP-tagged proteins were similar in
the GFP-TVAG_166850WT and GFP-TVAG_166850AG/FF mutant populations (Fig 6C, top
panel). However, the mean fluorescence intensity (MFI) of the GFP-TVAG_166850AG/FF
mutant population was consistently at least three-fold higher than the wild type population in
three independent experiments (a representative experiment is shown in Fig 6C, bottom
panel). The increased MFI signal observed in the GFP-TVAG_166850AG/FF population contin-
ued to be observed after growing the parasites in culture for several days and after freeze-thaw-
ing of the population, providing evidence for a robust and stable phenotype. Higher surface
staining of the rhomboid substrate MIC2 in T. gondii rhomboid knockout cells has also been
reported by Shen et al. [62]. Our data indicate that increased surface detection of the
GFP-TVAG_166850AG/FF mutant protein results from lack of cleavage by TvROM1, allowing
for its greater accumulation at the cell surface.
To determine the phenotypic effect of mutating the predicted rhomboid cleavage site in
GFP-TVAG_166850, we compared the attachment properties of the GFP-TVAG_166850WT
and GFP-TVAG_166850AG/FF mutant populations. Exogenous expression of GFP-TVAG_
166850WT led to a 1.3-fold increased attachment to host cells compared to empty vector trans-
fectants (p-value<0.05), while exogenous expression of the GFP-TVAG_166850AG/FF mutant
led to an even greater increase in attachment (1.7-fold) compared to empty vector (p-
value<0.01) (Fig 6D). The change in attachment between the mutant and wild type was statis-
tically significant (p-value<0.01). These data indicate that reduced TvROM1 cleavage leads to
the increased surface levels of the GFP-TVAG_166850AG/FF mutant protein (Fig 6C) which in
turn leads to increased attachment to host cells (Fig 6D). Incubation of GFP-TVAG_166850WT
and GFP-TVAG_166850AG/FF mutant populations with ectocervical cells in a four hour cytoly-
sis assay did not reveal a greater ability of the transfectants to lyse host cells (S5 Fig), indicating
additional factors likely modulate T. vaginalis cytolysis of host cells.
Discussion
We have characterized three putative rhomboid proteases in the human parasite T. vaginalis
and demonstrated that two, TvROM1 and TvROM3, are catalytically active and exhibit distinct
substrate specificity. TvROM3 cleaves the canonical rhomboid substrate Spitz in a heterolo-
gous cell cleavage assay while TvROM1 does not cleave Spitz but does cleave several known
Plasmodium rhomboid substrates [39, 44]. Immunofluorescence studies of exogenously
expressed HA-tagged TvROM1 and TvROM3 indicate that TvROM1 is a plasma membrane
protease whereas TvROM3 localizes to Golgi-like structures. Cellular localization studies of the
generate the GFP-TVAG_166850AG/FF mutant. (B) TvROM1 efficiently cleaves the wild type (wt) TVAG_166850 TM and not the TVAG_166850AG/FF mutant
TM. Proteases and chimeras of GFP-EBA-175 with the TVAG_166850 wt TM or mut TM were co-transfected in the heterologous cell cleavage assay. Lanes
1–5 = co-transfection with wild type GFP-EBA-175-TVAG_166850WT TM; lanes 6–10 = co-transfection with GFP-EBA-175-TVAG_166850AG/FF mutant TM.
Western blot analyses of whole cell lysates confirm expression of wt and mut rhomboid proteases (top panel) and the full length substrates (FL, middle
panel). Analyses of conditioned media show a GFP-tagged cleavage product in the media (red, open arrowhead, bottom panel) of TvROM1 co-transfected
with wild type TVAG_166850 (lane 4) which is reduced ~90% in mutant TVAG_166850AG/FF co-transfectants (lane 9). Co-transfection with mutant TvROM1
abolishes cleavage (lanes 5 & 10). Lanes 1 & 6 = no metalloprotease inhibitor BB-94, lane 2–5 & 7–10 = 10 μMmetalloprotease inhibitor BB-94. Lanes 3 &
8 = co-transfection with TgROM5 (control). (C) The GFP-TVAG_166850WT and GFP-TVAG_166850AG/FF mutant proteins were exogenously expressed in T.
vaginalis. Transfectants were stained with an anti-GFP antibody without permeabilization at 4°C to detect surface levels of the fusion protein quantified using
flow cytometry. Three cultures (cultures #1–3) in three independent experiments were analyzed. Representative results from one experiment are shown. Top
panel shows the GFP+ cell population, similar percentages of GFP+ cells were detected for the wt and mutant transfectants. Bottom histogram shows the
fluorescence intensity distribution of the GFP+ population. GFP-TVAG_166850AG/FF mutant transfectants had at least three-fold higher mean fluorescence
intensity (MFI) levels compared to wild type transfectants. (D) The ability of GFP-TVAG_166850WT and GFP-TVAG_166850AG/FF mutant transfectants to
attach to ectocervical cells was compared to empty vector transfectants. Results show the average of three experiments, each conducted in triplicate.
Exogenous expression of GFP-TVAG_166850WT leads to a statistically significant increase in attachment compared to empty vector transfectants (*p<0.05).
Overexpression of the GFP-TVAG_166850AG/FF mutant leads to an even greater increase in attachment compared to empty vector (**p<0.01) and wildtype
GFP-TVAG_166850WT transfectants (**p<0.01).
doi:10.1371/journal.ppat.1005294.g006
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endogenous proteins are yet to be done to corroborate the localization determined for the HA-
tagged proteins.
As a step towards defining the function of TvROMs, we identified nine putative T. vaginalis
surface substrates using both quantitative proteomic and bioinformatic approaches. Two of
these candidate substrates were shown to be TvROM1 substrates: TVAG_166850 and
TVAG_280090. These proteins have a high degree of similarity and are members of a gene
family consisting of over 150 members [20]. Interestingly, two other predicted substrates
(TVAG_244130 and TVAG_335250) are paralogs of TVAG_166850 and TVAG_280090; how-
ever their TM domains were not cleaved by TvROM1 in the heterologous cell cleavage assay.
Whether these putative substrates are cleaved by other proteases not examined in this study
remains to be determined. TvROM3 was not able to cleave any of the nine putative T. vaginalis
substrates identified, confirming that TvROM1 and TvROM3, which display different subcel-
lular localizations, also appear to have different substrate specificities.
We were not able to identify T. vaginalis substrates for either TvROM2 or TvROM3. How-
ever, given that the candidate substrates identified are members of large protein families,
untested members of these families or other unidentified proteins may serve as substrates for
these TvROMs. This is consistent with our observation that T. vaginalis surface proteomes con-
tain a subset of proteins encoded by large multi-gene families, with different subsets expressed
by different strains [23].
Amino acids surrounding the predicted cleavage sites in model rhomboid substrates cleaved
by TvROM1 and the T. vaginalis substrates are similar. There is an overall presence of small
amino acid residues surrounding the predicted cleavage site and indeed restriction of a small
amino acid at the P4 and P2’ sites in our parasite search motif was critical for bioinformatic
identification of the two T. vaginalis substrates cleaved by TvROM1. Nevertheless, finding that
TvROM1 cleaves only two of the five candidate substrates identified by bioinformatics under-
scores the difficulty in identifying substrates using search motifs. Overall, these analyses indi-
cate that TM dynamics may play a more important role in substrate selection than the
presence of specific amino acids surrounding the cleavage site.
We found that overexpression of TvROM1 significantly increases parasite attachment to
and lysis of host cells, which are two properties critical for the pathogenesis of T. vaginalis.
These data may be explained several ways. Signaling induced by cleavage of a TvROM substrate
during the initial phase of parasite-host interaction may lead to an increase in adherent surface
proteins on the parasite or host cell. This might be mediated by an initial low-affinity binding,
with cleavage driving a higher affinity binding, which in turn triggers host cell lysis. A role for
TvROM1 at the junction of adherence and cytolysis is consistent with the observation that
once a threshold of parasite attachment is reached, host cell cytolysis is triggered [17]. Exoge-
nous expression of the TVAG_166850 substrate with the predicted P1-P1’ rhomboid cleavage
site mutated to reduce TvROM1 cleavage leads to an even greater increase in parasite attach-
ment relative to exogenous expression of the wild type protein, consistent with a direct role for
this substrate in adherence and regulation of its function by TvROM1 cleavage. In this regard,
it is notable that using the Phyre2 program, both TVAG_166850 and TVAG_280090 have cad-
herin-like predicted secondary structures which are known to mediate cell: cell interactions in
eukaryotes [63].
The proteins identified in supernatants of T. vaginalis (S1 Table) together with proteins we
previously identified to be released in exosomes [64], compose, to our knowledge, the most
comprehensive analyses lists of proteins released/secreted by T. vaginalis to date. There is over-
lap between these two proteomes, with 70 of the 188 proteins identified here also being present
in the T. vaginalis exosome proteome (S1 Table). We identified cysteine proteases, which are
considered to be established and secreted virulence factors of T. vaginalis (reviewed in [65]).
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This list also provides experimental evidence for the release of proteins previously predicted to
be T. vaginalis secreted proteins, such as cysteine protease inhibitors called cystatins [66] and a
pore-forming/saposin-like protein hypothesized to help lyse host cells [20, 21, 67]. Other solu-
ble factors uncovered in this proteomic analysis may be candidates contributing to T. vaginalis
virulence.
In summary, we have identified two active T. vaginalis rhomboid proteases (TvROM1 and
TvROM3) and two TvROM1 substrates. We have shown that modulation of expression of
TvROM1 and its substrate plays a role in regulating host cell attachment and cytolysis dynam-
ics. These findings are significant as few proteins have been shown to contribute to both T.
vaginalis attachment and cytolysis of host cells (reviewed in [16]). The results of this study also
expand the finding that rhomboid proteases contribute to pathogenesis-associated processes in
parasites that pose important public health problems (reviewed in [68] and [69]). As both
human and TvROM1 substrate specificities are better defined, it may be possible to selectively
target T. vaginalis rhomboid proteases as therapeutic agents [70].
Materials and Methods
Growth of cells
The T. vaginalis strains G3 (ATCC PRA98) and RU393 (ATCC 50142) were grown as
described previously [71]. Parasites were incubated at 37°C and passaged daily for less than
two weeks. The human ectocervical cell line Ect1 E6/E7 (ATCC CRL-2614) was grown as
described [72].
TvROMs plasmid construction and exogenous expression in T. vaginalis
TvROMs were PCR amplified from G3 genomic DNA, using the primer pairs listed in S6 Fig.
PCR fragments were cloned into the Nt-HA-MasterNeo plasmid [23]. To increase the detec-
tion of tagged TvROMs, two additional HA tags were inserted to generate 3xHA-TvROMs by
ligation of hybridized oligos encoding two HA-tags into the NdeI restrictions sites. The
3xHA-TvROM-MasterNeo plasmid was then digested with ClaI to remove the fragment
encoding the neomycin phosphotransferase (Neo) selectable marker and its flanking 50 and 30
beta-tubulin untranslated regions (UTRs) and ligated to close the vector. A fragment encoding
the puromycin N-acetyltransferase gene flanked with alpha-SCS 50 and 30 UTRs previously
described in [73] was cloned into the Master (-Neo) plasmid using the ApaI restriction site.
Electroporation of the G3 and RU393 strains was performed as previously described [74]
and transfectants were selected with 100 μg/ml G418 (GIBCO) or 60 μg/ml puromycin dihy-
drochloride (A.G. Scientific, Inc.) and maintained with drug selection.
TvROMs indirect immunofluorescence assays
The subcellular localization of 3xHA-TvROM1 in RU393 transfectants was determined by cell
surface biotinylation of transfectants followed by IFA and imaging as described [23] except for
use of fewer parasites, 3.18×107 parasites in 30 ml. For localization of 3xHA-TvROM2 and
3xHA-TvROM3 in G3 transfectants, IFA was performed as described [75].
HEK293 heterologous cell cleavage assays and PfEBA-175 cleavage
site determination
The in vitro activities of TvROMs were analyzed with a heterologous cleavage assay derived
from [39]. Briefly, HEK293T (ATCC CRL-11268) cells were seeded in 12-well plates and co-
transfected at ~80% confluency with X-tremeGENE HP (Roche) and pcDNA3.1 (Invitrogen)
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expressing N-terminal GFP-tagged and/or C-terminal Flag-tagged substrates and N-terminal
3xHA-tagged rhomboid proteases. Cells were washed once and then conditioned with serum-
free DMEM 18-h post-transfection. Media and cell lysates were harvested 24-h later in
Laemmli buffer. Protein from lysates and media were separated on 4%-12% gradient Bis-Tris
and 4%-20% Tris-glycine gels, respectively, (Life Technology) and transferred onto nitrocellu-
lose membranes. Membranes were probed with anti-GFP (Abcam), anti-HA (Roche), or anti-
FLAG (Sigma) primary antibodies, anti-rabbit/rat/mouse secondary antibodies conjugated to
infrared fluorophores (Li-COR Biosciences) and imaged on an Odyssey infrared scanner (Li-
COR Biosciences). For cleavage site determination, HEK293T cells were transfected as
described, lysed in RIPA buffer, subjected to anti-FLAG immunopurification (Sigma) and ana-
lyzed by MALDI-TOF mass spectrometry as previously described [76]. TvROMs were ampli-
fied from G3 genomic DNA via PCR and cloned into the 3xHA pcDNA expression vector.
Like other parasitic rhomboid enzymes [39], TvROMs did not express in HEK293T cells and
were thus recoded for human expression (GeneArt).
TvROMs cytolysis and attachment assays
T. vaginalis adherence and cytolysis assays were performed as described [17]. To test the effect
of 3,4-dichloroisocoumarin (3,4-DCI, SIGMA) on parasite adherence, parasites were incubated
with 3,4-DCI or DMSO vehicle control in completed K-SFM media and added to ectocervical
cell monolayers. Adherence and cytolysis assays were performed as described [17], using three
or four hour incubation times for wildtype RU393 and RU393 3x-HA-TvROM1 transfectants,
respectively.
Stable isotope dimethyl labeling of cell supernatants and quantitative
proteomics
1×107 log-phase 3xHA-TvROM1 RU393 T. vaginalis transfectants in 100 ml of PBS+5%
sucrose were treated with 50 μM 3,4-DCI or DMSO vehicle control for one hour at 37°C. Para-
sites were pelleted and the supernatant was filtered through a 0.22 μm Steriflip™ 50 ml filter
(Millipore) and stored at -80°C. Upon thawing, supernatants were concentrated to ~300 μl
using an Amicon1 Ultra Centrifugal filter unit (3 kDa cutoff) and lyophilized. 25 μg of protein
from each sample was reduced, alkylated, and digested with Lys-C endopeptidase (Wako, Rich-
mond, VA) for four hours and trypsin for 14 hours (Thermo Scientific) as previously described
[77]. Digested peptides were desalted by HPLC using a Michrom Bioresources Microtrap col-
umn (2–20 μg binding capacity). Stable isotope dimethyl labeling was performed as described
[59], with the addition of an HPLC desalting step after peptide labeling followed by lyophiliza-
tion. Peptides from the vehicle control were labeled with the “light label” and 3,4-DCI samples
were labeled with the “intermediate label.” Labeled peptides were reconstituted in 0.2% formic
acid, and equal protein amounts were mixed. For mass spec analysis, 8 μl of a mixture contain-
ing 1 μg of each sample was separated on an analytical (75 μm ID) HPLC column packed in-
house with ReproSil-Pur C18AQ 3 μm resin (120 Å pore size, Ammerbuch, Germany) coupled
to an LTQ-Orbitrap Classic mass spectrometer (Thermo Scientific, Bremen, Germany) as
described [78] with the following modifications. The nanoflow LC system EASY nLC II gradi-
ent was as follows: 2–30% B (80 min), 30–100% B (1 min) and 100% B (8 min).
MS data analysis
MaxQuant (v. 1.4.1.2) was used to search Thermo RAW files [79]. Spectra were searched
against T. vaginalis (50623 entries) and a contaminant database (245 entries). MaxQuant gen-
erated decoy sequences (reversed peptide sequences) to estimate the false discovery rate. Search
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parameters included variable oxidation of methionine, variable protein N-terminal acetylation,
fixed carboxyamidomethylation of cysteine and dimethyl labeling of peptide N-terminus and
lysine. Trypsin was specified as the digestion enzyme with up to two missed cleavages. A 1%
false discovery rate threshold was applied for protein and peptide identifications. Precursor
mass tolerance was 7 ppm (or less for individual peptides). Fragment mass tolerance was 0.5
Da. Confidence intervals and p-values were calculated using a hierarchical model with boot-
strap resampling and pooled variance estimates as described [80]. P-values were adjusted using
the Benjamini and Hochberg method to correct for multiple hypothesis testing [81].
Heterologous cell cleavage assays
The transmembrane domains from candidate substrates were inserted into EBA-175 by inverse
PCR (Phusion, NEB) with primers encoding the new transmembrane domains at their 50 ends.
PCR products were purified (QiaQuick, Qiagen) and blunt ends were phosphorylated by T4
polynucleotide kinase (NEB), and ligated with T4 ligase (Roche). The chimeric molecules were
confirmed by DNA sequencing and analyzed for cleavage in the heterologous cleavage assay as
described above.
Site-directed mutagenesis, expression, and phenotypic analysis of
GFP-TVAG_166850WT and rhomboid cleavage-site mutant
GFP-TVAG_166850AG/FF
The plasmid encoding for TVAG_166850 with an N-terminal enhanced green fluorescent pro-
tein (eGFP) tag was constructed by cloning a eGFP PCR-amplified fragment into the NdeI and
SacII restriction sites of Nt-HA-MasterNeo, followed by ligation of the TVAG_166850 gene in-
frame using the SacII and BamHI restriction sites. The TVAG_166850AG/FF putative rhomboid
cleavage site mutant was generated by site-directed mutagenesis of the GFP-TVAG_166850
construct using the QuikChange kit (Stratagene) and primers that encoded the Ala672Phe and
Gly673Phe mutations (primers listed in S6 Fig). Plasmids were transfected into the poorly
adherent G3 strain for gain of function analysis, and selected with G418. Attachment to and
cytolysis of host cells was assayed as described above except the cytolysis assay was incubated
for 18 hrs.
Flow cytometry analysis of surface GFP-TVAG_166850WT and
GFP-TVAG_166850AG/FF mutant proteins
2×105 log-phase G3 transfectants were resuspended in FACS buffer (5% fetal bovine serum/
0.1% sodium azide/1× PBS) and assayed in triplicate. Parasites were stained with 1 μg/ml
mouse-anti-GFP (Clontech) and Empty vector transfectants were stained with only the sec-
ondary (2°) Ab as a control for background. Staining was detected with 1 μg/ml goat anti-
mouse-Alexa Fluor1488 2°Ab antibody. Antibody incubations were performed on ice for 30
min. Samples were analyzed on a Becton Dickinson Fortessa flow cytometer in the FITC chan-
nel. Empty vector 2°Ab alone samples were used to set the GFP+ population gates. The mean
fluorescence values were calculated for each sample, using the FlowJo 8.4 software. The experi-
ment was performed three times and representative data from one experiment is shown.
Supporting Information
S1 Fig. Alignment of TvROM 1–4 and predicted membrane topology. (A) Sequence align-
ment of the predicted active TvROMs 1–4 using the Multiple Sequence Comparison by Log-
Expectation (MUSCLE) program. Alignment was manually edited using the BioEdit program
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(“~” marks sites of manual insertion/deletion to aid alignment of critical residues, numbers
within the sequences indicate the number of residues omitted to allow optimal alignment).
Shading indicates 75% or greater sequence similarity. Lines above the TvROM1 sequence
marks predicted TM domains for TvROM1 using the Spoctopus signal peptide and membrane
protein topology prediction program. Similar TM domain predictions were obtained for
TvROM2 and TvROM4. TvROM3 lacks a predicted 7th TM domain and thus the C-terminal
tail is predicted to be intracellular. No signal peptides were predicted for TvROMs 1–4, and all
the proteins are predicted to have their N-terminus located inside the cell. Bold red letters indi-
cate residues participating in nucleophilic catalysis, while the green residues function in elec-
trophilic catalysis (oxyanion stabilization). Blue lettering highlights residues that form four
conserved Keystones that play key roles in maintaining rhomboid architecture (as defined
experimentally for bacterial rhomboid proteases in R.P. Baker & S. Urban, Nature Chemical
Biology, 2012). Briefly, the arginine (R) of Keystone I (E/QxWRxxS/TxxxxH) helps to stabilize
the L1 loop ‘hairpin’ by donating several hydrogen bonds to neighboring residues, while
GxxxExxxG of Keystone II stabilizes cytoplasmic interaction of TMs 1, 2 and 3 into an apex.
Keystone III (surrounding the catalytic serine) and Keystone IV (with a GxxxG dimerization
motif following the catalytic histidine base) mediate close apposition of TMs 4 and 6 at the
core of the enzyme. (B) Scheme shows the predicted topology of TvROM1, TvROM2, and
TvROM4 with 7 TM domains. TvROM3 has similar predicted topology but contains only the
first six TM domains. Reference: R.P. Baker and S. Urban. Architectural and thermodynamic
principles underlying intramembrane protease function. Nat Chem Biol. 2012: 8(9):759–768.
(TIFF)
S2 Fig. Additional cleavage activity analysis of TvROM1-3 using heterologous substrates.
The ability of T. vaginalis rhomboid proteases to cleave known model rhomboid substrates was
tested using the HEK293 heterologous cell cleavage assay. Proteases were HA tagged and sub-
strates contained an N-terminal GFP tag to allow detection. Whole cell lysates (WCL) and con-
ditioned media (CM) were collected from co-transfectants and analyzed by Western blot
analyses (Baker et al. 2006). Top panels: rhomboid protease detected in WCL using an anti-
HA antibody;middle panels: full-length (FL-filled arrowheads) and cleaved substrates (open
arrowheads) detected in WCL using an anti-GFP antibody; bottom panels: cleaved substrate
fragments detected in CM using an anti-GFP antibody (red, open arrowheads). The substrates
tested were (A) Plasmodium falciparum BAEBL, (B) human Ephrin-B3, (C) Plasmodium fal-
ciparum EBA-175, (D) Drosophila melanogaster Spitz, and (E) Providencia stuartii TatA. The
positive control protease for testing cleavage of Spitz and TatA (D and E) was DmRho1; the
positive control protease for Plasmodium BAEBL (A) and EBA-175 (C) was PfROM4; the posi-
tive control protease for EphrinB3 was TvROM1 (B). Negative controls lacked co-transfection
with a TvROM (Negative). TvROM1/TvROM2/TvROM3 = wild type protease; TvROM1 mut/
TvROM2 mut/TvROM3 mut = protease with the catalytic histidine mutated to alanine. In (B)
the heterologous cell cleavage assay was performed in the absence and presence of 10 μM Bati-
mastat (- or + BB-94), a metalloprotease inhibitor. TvROM1 can cleave Plasmodium BAEBL
(A-lane 3) and the TvROM1mut cannot (A-lane 4) indicative of TvROM-1 specific cleavage.
EphrinB3 and TatA are released into the media by both TvROM2 and TvROM2mut co-trans-
fectants (B-lanes 3 and 4 and E-lanes 4 and 5), therefore it does not appear to be TvROM2-spe-
cific cleavage. To further investigate this, TvROM2 cleavage of EphrinB3 was tested in the
presence of a metalloprotease inhibitor and release of EphrinB3 above background was no lon-
ger observed (B-lanes 7 and 8). References: Baker, R. P., R. Wijetilaka and S. Urban (2006).
PLoS Pathog 2(10): e113.
(TIF)
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S3 Fig. TvROM1 and TvROM3 are not able to cleave remaining putative substrates from
dimethyl labeling mass spectrometry experiments. The HEK293 heterologous cell cleavage
assay was used to test cleavage of the TM domain of the putative substrates identified in the
quantitative proteomics experiment (Fig 4). A plasmid encoding a chimeric protein composed
of GFP-P. falciparum EBA-175 with the TM domain replaced with that of the putative sub-
strates, was co-transfected with a plasmid encoding for wild type HA-TvROM1 or HA-Tv-
ROM3, or catalytic His to Ala mutants (mut). The chimeric protein tested is indicated above
each blot. Negative controls lacked co-transfection with a TvROM (Negative). Western blot
analysis of whole cell lysates (WCL) and conditioned media (CM) from co-transfectants was
performed with an anti-GFP antibody to test for the presence of a smaller GFP-EBA-175 frag-
ment released into the media by TvROM1 cleavage (bottom panel) or detected in cell lysates if
cleaved by TvROM3 (middle panel). An open red arrowhead marks the location of the
expected molecular weight for the cleavage product if cleavage had occurred. An anti-HA anti-
body was used to confirm expression of TvROM1 and TvROM3 wt and mut proteins (top
panel). Full-length (FL) chimeric substrate in WCL is annotated with a filled arrowhead (mid-
dle panel). The chimeric protein EBA-175 with the TM domain of TVAG_573910 (A) was
released into the media even in the absence of co-transfection with TvROM1 or TvROM3 (A-
lane 1, bottom panel), therefore the heterologous cell cleavage assay was performed in the pres-
ence of 10 μM Batimastat (A-lanes 2–7), a metalloprotease inhibitor. Release of the chimeric
protein was still detected when no TvROM was co-transfected and in the presence of the inhib-
itor (A bottom panel-lane 2), thus we do not consider the products released into the media
(bottom panel) to be generated by TvROM-specific cleavage. No differences in the amount of
cleavage product could be detected for the other substrates (B) TVAG_245580, (C)
TVAG_425470, and (D) TVAG_393390) between wildtype and catalytic mutants and thus do
not consider the products to be generated by rhomboid protease-specific cleavage.
(TIF)
S4 Fig. Additional cleavage analysis of putative surface proteome substrates. The HEK293
heterologous cell cleavage assay was used to test the cleavage of the TM domain of the putative
substrates identified in the screen of the surface proteome with the parasite search motif (Fig
5). A plasmid encoding a chimeric protein composed of GFP-P. falciparum EBA-175 with the
TM domain replaced with that of the putative substrates (A-E), was co-transfected with a plas-
mid encoding for wildtype HA-TvROMs 1–3 or catalytic His to Ala mutants (mut). The chi-
meric protein tested is indicated above each blot. Negative controls lacked co-transfection with
a TvROM (Negative). Western blot analysis of whole cell lysates and conditioned media from
co-transfectants was performed with an anti-GFP antibody to test for the presence of a smaller
GFP-EBA-175 fragment released into the media by TvROM1 cleavage or detected in cell lysates
if cleaved by TvROM2 or TvROM3. An anti-HA antibody was used to confirm expression of
the HA-TvROMs wt and mut proteins (top panel). Full-length chimeric substrate is annotated
with a filled arrowhead (FL-middle panel). A red open arrowhead marks the expected molecu-
lar weight of the cleavage product. As positive controls, the cleavage of TVAG_166850 and
TVAG_280090 by TvROM1 is shown (A and B-lanes 2 and 3). The chimeric protein EBA-175
with the TM domain of TVAG_280090 (B-lanes 4 and 5), TVAG_244130 (C-lanes 4 and 5),
TVAG_335250 (D-lanes 4 and 5), and TVAG_189150 (E-lanes 4 and 5) was released into the
media of HA-TVROM2 wt and catalytic mutant co-transfectants, thus these are not considered
to be specific TvROM2-generated cleavage products. (F) The full length GFP-TVAG_280090
protein can be cleaved by DmRho1 and detected in whole cell lysates (middle panel-lane 4,
open arrowhead) and conditioned media (bottom panel, lane 4, red arrowhead). White line
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denotes cutting out of extraneous lanes in the blot.
(TIF)
S5 Fig. Predicted rhomboid cleavage site mutation in the putative substrate TVAG_166850
does not lead to changes in host cell cytolysis. Negative control Empty vector transfectants
and transfectants exogenously expressing wild type GFP-TVAG_166850 and GFP-TVAG_
166850 AG/FF containing mutations in the predicted P1-P1’ cleavage site residues were incu-
bated with ectocervical cell monolayers and host cell lysis was assessed. The average fold
change in cytolysis of the transfectants expressing wild type or mutant TVAG_166850, relative
to that of empty vector transfectants, is shown for four experiments performed in triplicate.
Error bars denote the standard error. No statistically significant difference in host cell lysis was
observed.
(TIF)
S6 Fig. Primers used in this study.
(PDF)
S1 Table. Total list of proteins identified in the stable isotope dimethyl labeling quantita-
tive proteomics experiments.
(XLSX)
S2 Table. Results from surface proteome screen using the parasite search motif.
(XLS)
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